• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过转录组测序探索顺铂耐药的机制,并通过自噬抑制逆转小细胞肺癌的化疗耐药性。

Exploring the mechanism of cisplatin resistance by transcriptome sequencing and reversing the chemoresistance by autophagy inhibition in small cell lung cancer.

机构信息

School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, PR China.

School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Key Laboratory of Cancer Invasion & Metastasis Research, Beijing, 100069, PR China.

出版信息

Biochem Biophys Res Commun. 2020 Dec 10;533(3):474-480. doi: 10.1016/j.bbrc.2020.09.023. Epub 2020 Sep 22.

DOI:10.1016/j.bbrc.2020.09.023
PMID:32977950
Abstract

Cisplatin plays a key role in treating small cell lung cancer (SCLC); however, the rapid development of cisplatin resistance limits its treatment effect. The detailed mechanisms of cisplatin-resistance, particularly in SCLC, remain unclear. We analyzed the differentially expressed genes (DEGs) between cisplatin-resistant small cell lung cancer cell line H446/CDDP and its parental cell line H446, using the transcriptome sequencing technique. Gene ontology (GO) analysis and the subsequent tests demonstrated that the functions of protein ubiquitination and autophagy are more active in the H446/CDDP cells. Autophagy plays a protective role in the H446/CDDP cells by using the autophagy inhibitors, 3-methyladenine and bafilomycin A1. Moreover, antimalarial drugs that inhibit autophagy by increasing the pH of lysosomes can also enhance cisplatin-induced cell death.

摘要

顺铂在治疗小细胞肺癌(SCLC)中起着关键作用;然而,顺铂耐药的快速发展限制了其治疗效果。顺铂耐药的详细机制,特别是在 SCLC 中,仍然不清楚。我们使用转录组测序技术分析了顺铂耐药小细胞肺癌细胞系 H446/CDDP 与其亲本细胞系 H446 之间的差异表达基因(DEGs)。基因本体(GO)分析和随后的测试表明,H446/CDDP 细胞中蛋白质泛素化和自噬的功能更为活跃。自噬通过使用自噬抑制剂 3-甲基腺嘌呤和巴弗洛霉素 A1 在 H446/CDDP 细胞中发挥保护作用。此外,通过增加溶酶体 pH 值抑制自噬的抗疟药物也可以增强顺铂诱导的细胞死亡。

相似文献

1
Exploring the mechanism of cisplatin resistance by transcriptome sequencing and reversing the chemoresistance by autophagy inhibition in small cell lung cancer.通过转录组测序探索顺铂耐药的机制,并通过自噬抑制逆转小细胞肺癌的化疗耐药性。
Biochem Biophys Res Commun. 2020 Dec 10;533(3):474-480. doi: 10.1016/j.bbrc.2020.09.023. Epub 2020 Sep 22.
2
Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.抑制 p62/SQSTM1 通过靶向 NEDD9 表达使小细胞肺癌细胞对顺铂诱导的细胞毒性敏感。
Mol Carcinog. 2020 Aug;59(8):967-979. doi: 10.1002/mc.23215. Epub 2020 May 19.
3
Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells.Fas 的上调逆转了人小细胞肺癌细胞对顺铂的耐药性。
J Exp Clin Cancer Res. 2010 May 14;29(1):49. doi: 10.1186/1756-9966-29-49.
4
MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation.微小 RNA-137 下调 KIT 并抑制小细胞肺癌细胞增殖。
Biomed Pharmacother. 2014 Feb;68(1):7-12. doi: 10.1016/j.biopha.2013.12.002. Epub 2013 Dec 24.
5
Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.Mir-24-3p下调通过靶向自噬相关蛋白4A(ATG4A)导致小细胞肺癌对依托泊苷和顺铂(VP16-DDP)耐药。
Oncotarget. 2015 Jan 1;6(1):317-31. doi: 10.18632/oncotarget.2787.
6
Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.成纤维细胞生长因子诱导蛋白14通过核因子κB途径调节小细胞肺癌的细胞生长和多药耐药性。
Anticancer Drugs. 2014 Nov;25(10):1152-64. doi: 10.1097/CAD.0000000000000153.
7
Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.Src 同源磷酸酪氨酸磷酸酶 2 通过抑制细胞凋亡和激活 Ras/PI3K/Akt1/survivin 通路介导肺癌细胞对顺铂相关药物耐药。
Oncol Rep. 2018 Feb;39(2):611-618. doi: 10.3892/or.2017.6109. Epub 2017 Nov 24.
8
Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer.机制探索:电压依赖性钙通道α2δ1 亚基介导的小细胞肺癌肿瘤干细胞标志物与化疗耐药的关系。
Clin Cancer Res. 2018 May 1;24(9):2148-2158. doi: 10.1158/1078-0432.CCR-17-1932. Epub 2018 Feb 6.
9
Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.内向整流钾通道Kir2.1(KCNJ2)的上调在miR-7和Ras/MAPK信号通路的调控下调节小细胞肺癌的多药耐药性。
Mol Cancer. 2015 Mar 12;14:59. doi: 10.1186/s12943-015-0298-0.
10
mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer.突变与小细胞肺癌中顺铂敏感性和肿瘤突变负担相关。
Aging (Albany NY). 2020 Jan 20;12(2):1285-1303. doi: 10.18632/aging.102683.

引用本文的文献

1
Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1 pathway.克服小细胞肺癌的多药耐药性:联合 venetoclax 和羟氯喹靶向 lncRNA LYPLAL1-DT/BCL2/BECN1 通路的协同方法。
Mol Cancer. 2024 Oct 31;23(1):243. doi: 10.1186/s12943-024-02145-1.
2
CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung Cancer.CDK4/6 抑制剂可阻碍小细胞肺癌的化疗耐药并抑制肿瘤生长。
Adv Sci (Weinh). 2024 Oct;11(38):e2400666. doi: 10.1002/advs.202400666. Epub 2024 Aug 13.
3
Overcoming flumatinib resistance in chronic myeloid leukaemia: Insights into cellular mechanisms and ivermectin's therapeutic potential.
克服慢性髓性白血病中的 flumatinib 耐药性:对细胞机制和伊维菌素治疗潜力的深入了解。
J Cell Mol Med. 2024 Jul;28(14):e18539. doi: 10.1111/jcmm.18539.
4
Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies.增强癌症治疗中的疗效:将纳米医学与自噬抑制策略相结合
ACS Omega. 2024 Jun 18;9(26):27832-27852. doi: 10.1021/acsomega.4c02234. eCollection 2024 Jul 2.
5
Expression of miR-152 in cervical cancer and its influence on cisplatin resistance.miR-152 在宫颈癌中的表达及其对顺铂耐药性的影响。
Afr Health Sci. 2023 Jun;23(2):246-255. doi: 10.4314/ahs.v23i2.28.
6
New insights into the interaction between m6A modification and lncRNA in cancer drug resistance.m6A 修饰与长链非编码 RNA 在癌症耐药性中相互作用的新见解。
Cell Prolif. 2024 Apr;57(4):e13578. doi: 10.1111/cpr.13578. Epub 2023 Nov 14.
7
IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation.IGF2BP3 通过 m6A RNA 甲基化调控 TMA7 介导的自噬和顺铂耐药性在喉癌中。
Int J Biol Sci. 2023 Feb 22;19(5):1382-1400. doi: 10.7150/ijbs.80921. eCollection 2023.
8
Comparative characteristics of small cell lung cancer and Ewing's sarcoma: a narrative review.小细胞肺癌与尤因肉瘤的比较特征:一篇叙述性综述
Transl Lung Cancer Res. 2022 Jun;11(6):1185-1198. doi: 10.21037/tlcr-22-58.
9
Therapeutic potential of autophagy activators and inhibitors in lung and breast cancer- a review.自噬激活剂和抑制剂在肺癌和乳腺癌中的治疗潜力——综述。
Mol Biol Rep. 2022 Nov;49(11):10783-10795. doi: 10.1007/s11033-022-07711-8. Epub 2022 Jul 12.
10
Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells.干扰素调节因子-1 调控 A549 肺癌细胞中顺铂诱导的细胞凋亡和自噬。
Med Oncol. 2022 Jan 29;39(4):38. doi: 10.1007/s12032-021-01638-z.